Aoki M - Search Results

1

Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit.

Futagami M, Yokoyama Y, Iino K, Aoki M, Shoji T, Sugiyama T, Ariga H, Tokunaga H, Takano T, Watanabe Y, Yaegashi N, Jingu K, Sato N, Terada Y, Anbai A, Ohta T, Kurachi H, Kuroda Y, Nishiyama H, Fujimori K, Watanabe T, Sato H, Tase T, Wada H, Mizunuma H. Futagami M, et al. Among authors: aoki m. Int J Clin Oncol. 2015 Oct;20(5):1005-11. doi: 10.1007/s10147-015-0803-x. Epub 2015 Feb 24. Int J Clin Oncol. 2015. PMID: 25708593

2

Response of unresectable pancreatic cancer to intraoperative radiotherapy.

Mariya Y, Aoki M, Anbai A, Matsukura H, Abe Y, Kimura T, Matsuda K, Ohnuma H, Yokoyama S. Mariya Y, et al. Among authors: aoki m. Radiat Med. 1998 May-Jun;16(3):195-200. Radiat Med. 1998. PMID: 9715998

3

Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.

Hasegawa Y, Takanashi S, Okudera K, Aoki M, Basaki K, Kondo H, Takahata T, Yasui-Furukori N, Tateishi T, Abe Y, Okumura K. Hasegawa Y, et al. Among authors: aoki m. Jpn J Clin Oncol. 2004 Nov;34(11):647-53. doi: 10.1093/jjco/hyh119. Jpn J Clin Oncol. 2004. PMID: 15613553 Clinical Trial.

4

Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.

Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S. Basaki K, et al. Among authors: aoki m. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):449-54. doi: 10.1016/j.ijrobp.2005.07.967. Epub 2005 Oct 13. Int J Radiat Oncol Biol Phys. 2006. PMID: 16226400

5

Impact of dexamethasone, etoposide, ifosfamide and carboplatin as concurrent chemoradiotherapy agents for nasal natural killer/T-cell lymphoma.

Hatayama Y, Aoki M, Kawaguchi H, Narita Y, Hirose K, Sato M, Takai Y. Hatayama Y, et al. Among authors: aoki m. Mol Clin Oncol. 2013 Jul;1(4):680-684. doi: 10.3892/mco.2013.123. Epub 2013 May 17. Mol Clin Oncol. 2013. PMID: 24649228 Free PMC article.

6

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y. Koie T, et al. Among authors: aoki m. World J Surg Oncol. 2014 Apr 30;12:134. doi: 10.1186/1477-7819-12-134. World J Surg Oncol. 2014. PMID: 24885947 Free PMC article.

7

The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.

Mizunuma M, Yokoyama Y, Futagami M, Aoki M, Takai Y, Mizunuma H. Mizunuma M, et al. Among authors: aoki m. Int J Clin Oncol. 2015 Oct;20(5):989-96. doi: 10.1007/s10147-015-0807-6. Epub 2015 Mar 4. Int J Clin Oncol. 2015. PMID: 25736530

8

Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer.

Jingu K, Matsuo Y, Onishi H, Yamamoto T, Aoki M, Murakami Y, Yamashita H, Kakuhara H, Nemoto K, Sakayauchi T, Okamoto M, Niibe Y, Nagata Y, Ogawa K. Jingu K, et al. Among authors: aoki m. Anticancer Res. 2017 May;37(5):2709-2713. doi: 10.21873/anticanres.11621. Anticancer Res. 2017. PMID: 28476849

9

Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.

Niibe Y, Yamamoto T, Onishi H, Yamashita H, Katsui K, Matsumoto Y, Oh RJ, Aoki M, Shintani T, Yamada K, Kobayashi M, Ozaki M, Manabe Y, Yahara K, Nishikawa A, Kakuhara H, Yamamoto K, Inoue T, Takada YU, Nagata K, Suzuki O, Terahara A, Jingu K. Niibe Y, et al. Among authors: aoki m. Anticancer Res. 2020 Jan;40(1):393-399. doi: 10.21873/anticanres.13965. Anticancer Res. 2020. PMID: 31892592

10

Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.

Yamamoto T, Niibe Y, Matsumoto Y, Dekura Y, Oh RJ, Yamashita H, Kakuhara H, Aoki M, Jingu K. Yamamoto T, et al. Among authors: aoki m. Anticancer Res. 2020 Apr;40(4):2065-2072. doi: 10.21873/anticanres.14164. Anticancer Res. 2020. PMID: 32234898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,574 results

Search Page